United Therapeutics Corporation (UTHR) Debt Components
- 2016-06-30: Convertible Notes Payable, CurrentUSD $900.00K; Notes Payable, CurrentUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2016-03-31: Convertible Notes Payable, CurrentUSD $5.40M; Notes Payable, CurrentUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2015-12-31: Convertible Notes Payable, CurrentUSD $5.40M; Notes Payable, CurrentUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
- 2015-09-30: Convertible Notes Payable, CurrentUSD $30.02M; Notes Payable, CurrentUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m).
United Therapeutics Corporation Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Notes Payable, Current USD | Debt Instrument, Interest Rate, Stated Percentage pure |
|---|---|---|---|
| 2016-06-30 | $900.00K | (m) | (m) |
| 2016-03-31 | $5.40M | (m) | (m) |
| 2015-12-31 | $5.40M | (m) | (m) |
| 2015-09-30 | $30.02M | (m) | (m) |
| 2015-06-30 | $32.28M | (m) | (m) |
| 2015-03-31 | $115.22M | (m) | (m) |
| 2014-12-31 | $126.41M | (m) | (m) |
| 2014-12-31 | (m) | $67.00K | (m) |
| 2014-09-30 | $224.70M | $66.61M | (m) |
| 2014-06-30 | $221.71M | $141.61M | (m) |
| 2014-03-31 | $218.74M | $66.61M | (m) |
| 2013-12-31 | $215.84M | $66.61M | (m) |
| 2013-09-30 | $212.97M | (m) | (m) |
| 2013-06-30 | $210.17M | (m) | (m) |
| 2012-12-31 | (m) | $1.29M | (m) |
| 2011-09-30 | $248.54M | (m) | 0.50% |
| 2011-06-30 | $244.27M | (m) | 0.50% |
| 2011-03-31 | $240.08M | (m) | (m) |
| 2010-12-31 | $235.97M | (m) | (m) |
| 2010-12-31 | (m) | (m) | 0.50% |
| 2010-09-30 | $231.93M | (m) | (m) |
| 2010-06-30 | $227.98M | (m) | (m) |
| 2009-12-31 | $220.27M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |